GALERA THERAPEUTICS INC (GRTX) earnings

GRTX earnings moved a median of -1.24% by the close. Quarterly and annual GRTX reports and results, each read against the price at its own news timestamp. Back to the GRTX overview →

14 measured GRTX earnings events.

Where these GRTX earnings landedvs 13 measured GRTX earnings reactions
GRTX earningsMiddle 50% · -6.73% to -0.79%Zero: 0.00%Median: -1.24%Median -1.24%-10.00%0+10.00%
Middle 50% of GRTX earnings reactions-6.73% to -0.79%
Median reaction (to close)-1.24%
Measured reactions13
Point-in-time · zero look-ahead

Half of the 13 GRTX earnings events with a measured close landed between -6.73% and -0.79%; 8% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Galera Therapeutics, For: Mar 31SEC filing · Form 10-Q+0.00%+0.00%
Form 10-K Galera Therapeutics, For: Dec 31SEC filing · Form 10-K-2.39%+7.38%
Form 10-Q Galera Therapeutics, For: Sep 30SEC filing · Form 10-Q——
Form 10-Q Galera Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.00%-7.28%
Form 10-Q Galera Therapeutics, For: Mar 31SEC filing · Form 10-Q-5.35%-1.24%
Form 10-K Galera Therapeutics, For: Dec 31SEC filing · Form 10-K+0.00%-0.92%
Form 10-Q Galera Therapeutics, For: Sep 30SEC filing · Form 10-Q-33.12%-4.46%
Form NT 10-Q Galera Therapeutics, For: Sep 30SEC filing · Form NT+3.75%+0.00%
Form 10-Q Galera Therapeutics, For: Jun 30SEC filing · Form 10-Q+7.82%-11.91%
Form 10-Q Galera Therapeutics, For: Mar 31SEC filing · Form 10-Q—-0.79%
Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesPress release—-0.79%
Form 10-K Galera Therapeutics, For: Dec 31SEC filing · Form 10-K-0.69%-12.50%
Form 10-Q Galera Therapeutics, For: Sep 30SEC filing · Form 10-Q-3.73%-6.73%
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesPress release-3.73%-6.73%
That’s how GRTX usually reacts to earnings — get an email when it moves on news →
Keep exploring

More GRTX: analyst actions → · SEC filings → · GRTX overview →